IL1R1 and gastric cancer: The observation that loss of IL-1RT1 signaling in the gp130757FF mouse produces more pathology was unexpected considering that high expressing IL-1β polymorphic variants correlate with increased gastric cancer risk in Caucasians, and transgenic overexpression of IL-1β in mice results in severe gastric and esophageal pathology [4, 8].